Hodgkin’s Lymphoma

Clinical Trial Shows Best Outcomes to Date for Older Hodgkin Lymphoma Patients (09-18-2018)

Recently published results of a phase 2 clinical trial have shown the best outcomes to date for newly diagnosed older Hodgkin lymphoma patients treated with brentuximab vedotin given before and after doxorubicin, vinblastine and dacarbazine (AVD) chemotherapy,... Continue Reading

FDA Approves Adcetris® in Combination with Chemotherapy for Previously Untreated Stage III or IV Classical Hodgkin Lymphoma (03-22-2018)

CancerConnect News: The U.S. Food and Drug Administration (FDA) has approved Adcetris (brentuximab vedotin) in combination with chemotherapy in adult patients with previously untreated Stage III or IV classical Hodgkin lymphoma. The approval is based... Continue Reading

Addition of the Precision Cancer Medicine Adcetris Reduces the Risk of Treatment Failure in Advanced Hodgkin Lymphoma (03-1-2018)

CancerConnect News: Patients with advanced Hodgkin lymphoma (HL) who were treated with a multi-drug regimen that included the precision cancer medicine Adcetris (brentuximab vedotin) had a 23-percent reduction in the risk of disease progression, death,... Continue Reading

Lymphoma Patients: Understanding Peripheral Neuropathy (02-6-2009)

If you’ve received chemotherapy as part of your lymphoma treatment, one of the side effects you may experience is numbness and tingling in you extremities, also known as peripheral neuropathy. The following guidelines explain how to recognize and manage... Continue Reading

It’s Not Just a Little Fever: Preventing Infection during Therapy for Lymphoma (02-6-2009)

Many cancer patients are at an increased risk of infection because of their low levels of infection-fighting white blood cells, a condition called neutropenia. The most common reason that cancer patients experience neutropenia is as a side effect of chemotherapy.... Continue Reading

Successful Treatment for Lymphoma Means Staying on Schedule (02-6-2009)

In order to receive the best possible benefit from your lymphoma therapy, it is important to follow your treatment as your doctor has prescribed. Even if you’re not able to visit your regular treatment facility, chances are good that you can still... Continue Reading

Understanding Stem Cell Transplants (02-6-2009)

High-dose chemotherapy and bone marrow or blood stem cell transplantation (SCT) remains the best treatment available for selected patients with certain types of leukemia. The SCT process was developed more than 36 years ago and was considered such a major... Continue Reading

Hodgkin’s Survivors: Increased Fatigue, Cardiac, and Thyroid Complications (02-5-2009)

According to an article published in the Annals of Oncology, survivors of Hodgkin’s lymphoma have a significantly increased rate of cardiac and thyroid complications than their siblings. In addition, survivors tend to have more fatigue than their siblings;... Continue Reading

Patients with Hodgkin’s Lymphoma at Risk for Heart Attack Later in Life (02-5-2009)

Patients treated for Hodgkin’s lymphoma are at an increased risk of death from a heart attack for 25 years following therapy. In order to reduce the risk of death from cardiac complications, individuals diagnosed with Hodgkin’s lymphoma may wish... Continue Reading

What You Should Know About Bone Marrow Biopsy for the Staging of Lymphoma (02-5-2009)

Cancers that begin in cells of the lymph system are referred to as malignant lymphomas. The lymph system includes the spleen, thymus, tonsils, bone marrow, lymph nodes and circulating white blood cells called lymphocytes. Lymphocytes and the lymph system... Continue Reading

Next Page »